talquetamab
janssen
['multiple myeloma', 'talquetamab', 'monumental-1', 'multiplemyeloma']
rt from medshronline the monumental-1 phase 1/2 trial investigated the efficacy and safety of talquetamab for patients with relapsed/refractory multiple myeloma.
learn more about this study on medshr: #multiplemyeloma #ash22 
Digital Marketing Lead @medshronline